NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea
· Delayed Price · Currency is KRW 1,083.00
+17.00 (1.59%)
May 14, 2025, 12:39 PM KST
NeoImmuneTech Revenue
In the year 2024, NeoImmuneTech had annual revenue of 170.38M KRW. NeoImmuneTech had revenue of -920.38M in the quarter ending December 31, 2024.
Revenue
170.38M
Revenue Growth
n/a
P/S Ratio
123.71
Revenue / Employee
2.08M
Employees
82
Market Cap
21.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.07T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 11.24T |
| Kia Corporation | 107.45T |
| HD Hyundai Heavy Industries | 14.49T |